Modular Bioprocessing System for CAR-T Cell Manufacturing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing bioprocessing systems for CAR-T cell therapy are cumbersome, costly, and inflexible, with high contamination risks due to extensive human handling and limited automation, which hampers efficient production and consistency in volume manufacturing.

Innovation Solution

A modular bioprocessing system comprising distinct modules for cell enrichment, activation, genetic modification, and expansion, allowing for parallel processing and minimizing human intervention through automated fluid management and closed-system operations, enabling flexible and scalable production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If extensive human handling is used in existing bioprocessing systems, then operational flexibility is maintained, but contamination risk increases and automation extent decreases

Engineering Contradiction:
Improvecontamination riskVSAvoidautomation extent
Core Design Contradiction:
ReliabilityVSExtent of automation

Solution Approach 1:

The bioprocessing system is divided into multiple independent modules (cell enrichment module, activation module, genetic modification module, expansion module) that can be connected via standardized interfaces. This segmentation enables automated fluid management between modules while minimizing human intervention points, thus reducing contamination risk without sacrificing operational flexibility.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Automated fluid management systems act as intermediaries between modules, transferring cells and reagents without direct human contact. This intermediary mechanism reduces contamination risk by eliminating human handling while maintaining the ability to flexibly control process parameters through automated interfaces.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If distinct modules are used for cell enrichment, activation, genetic modification, and expansion, then productivity is enhanced through parallel processing, but device complexity increases

Engineering Contradiction:
Improveproduction efficiencyVSAvoidsystem complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

Each module is designed with standardized interfaces and can perform its specific function (enrichment, activation, genetic modification, or expansion) with multiple different cell types and protocols. This universality allows parallel processing of multiple cell products simultaneously, enhancing productivity while managing complexity through modular standardization.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

By segmenting the bioprocessing system into distinct functional modules with standardized interfaces, the system enables parallel processing operations. Each module can operate independently and simultaneously, increasing overall productivity while the modular structure actually reduces complexity compared to a monolithic system by allowing independent optimization and maintenance of each module.

Inventive Principle:
Principle #1Segmentation

3Ease of operation

If automated fluid management is implemented, then ease of operation is improved through minimized human intervention, but device complexity increases

Engineering Contradiction:
Improveease of operationVSAvoidsystem complexity
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The automated fluid management system enables modules to self-regulate fluid transfer, mixing, and processing operations without human intervention. The system automatically manages reagent delivery, cell transfer, and process monitoring, improving ease of operation while the modular architecture keeps complexity manageable through standardized, interchangeable components.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

Automated fluid management systems serve as intermediaries that handle complex fluid handling tasks between modules, improving ease of operation by eliminating manual intervention. The standardized interfaces and automated protocols simplify user interaction while the underlying complexity is encapsulated within the modular system architecture.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Adaptability or versatility

If modular system architecture is used for parallel processing, then adaptability is enhanced for different cell therapy protocols, but device complexity increases

Engineering Contradiction:
Improveprotocol flexibilityVSAvoidsystem complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The modular architecture with standardized interfaces allows different module configurations to support various cell therapy protocols (CAR-T, TCR-T, NK cell therapy, etc.). Each module can be adapted to different protocols through standardized connections, enhancing versatility while managing complexity through modular standardization that allows independent optimization of each component.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS11932842B2Bioprocessing apparatus
Publication Date: 2024.03.19 GLOBAL LIFE SCIENCES SOLUTIONS USA LLC
  • US11932842B2 patent drawing
  • US11932842B2 patent drawing
  • US11932842B2 patent drawing

AI summary

An apparatus for bioprocessing includes a housing, a drawer receivable within the housing, the drawer including a plurality of sidewalls and a bottom defining a processing chamber, and a generally open top, the drawer being movable between a closed position in which the drawer is received within the housing, and an open position in which the drawer extends from the housing enabling access to the processing chamber through the open top, and at least one bed plate positioned within the processing chamber and configured to receive a bioreactor vessel.